Stanford University

Total Awards: 
134
Award Value: 
$367,393,387
Major Facility Name: 
Lorry I. Lokey Stem Cell Research Building
Institution type: 
Not for profit

Short Name: 
Stanford

Awards to the Institution

Program Investigator Award Title Award Value
Preclinical Development Awards Matthew Porteus Pre-clinical development of gene correction therapy of hematopoietic stem cells for SCID-X1 $874,877
Comprehensive Grant Roel Nusse Guiding the developmental program of human embryonic stem cells by isolated Wnt factors $1,710,462
Quest - Discovery Stage Research Projects Helen Blau Stimulating endogenous muscle stem cells to counter muscle atrophy $2,198,687
Early Translational III Helen Blau Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients $1,825,920
New Faculty Physician Scientist Michelle Monje White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” $2,800,536
New Cell Lines Julie Baker Derivation of hESC Lines with Disease Lesions $1,404,725
Conference Thomas Rando Third Annual Symposium on Regenerative Rehabilitation $20,000
New Faculty I Howard Chang Noncoding RNAs in Cell Fate Determination $2,985,894
Genomics Centers of Excellence Awards (R) Michael Snyder Center of Excellence for Stem Cell Genomics - Stanford $22,796,609
SEED Grant Susan McConnell Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease $607,363
Late Stage Preclinical Projects Gary Steinberg Intraparenchymal NR1 Stem Cell Therapy for Chronic Subcortical Ischemic Stroke $5,300,000
Research Training II Theo Palmer Stanford CIRM Training Program $7,017,629
Basic Biology IV Anne Brunet Energy metabolism and aging pathways in human stem cell reprogramming and differentiation $1,414,044
Basic Biology II Garry Nolan Kinase signaling analysis of iPS cell reprogramming and differentiation $1,343,100
Inception - Discovery Stage Research Projects Jeffrey Goldberg Embryonic Stem Cells for Corneal Endothelial Degeneration $235,836
Tools and Technologies I Helen Blau Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells $949,608
Quest - Discovery Stage Research Projects Philip Beachy Pluripotent stem cell-derived bladder epithelial progenitors for definitive cell replacement therapy of bladder cancer $1,415,016
Basic Biology V Helen Blau Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging $1,175,357
SEED Grant Aaron Hsueh Patient-specific cells with nuclear transfer $629,653
Tool Translational Research Projects Joseph Wu A Novel, Robust and Comprehensive Predictive Tool Using Human Disease-Specific Induced Pluripotent Stem Cells for Preclinical Drug Screening $1,000,000
Tools and Technologies II Irving Weissman Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs $1,463,814
SPARK Paul Utz Stem Cell and Regenerative Medicine- Summer Research Internship $392,975
Comprehensive Grant Julie Baker Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cells $2,518,303
Quest - Discovery Stage Research Projects Irving Weissman Towards hepatocyte cell replacement therapy: developing a renewable source of human hepatocytes from pluripotent stem cells $1,968,456
Early Translational III Bertha Chen Autologous iPSC Therapy for Urinary Incontinence $4,715,738
Tissue Collection for Disease Modeling Joachim Hallmayer Induced pluripotent stem cells from children with autism spectrum disorders $530,265
New Cell Lines Michele Calos Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses $1,406,875
Conference Fan Yang 2014 Materials Research Society (MRS) Spring Meeting: Symposium Y: Biomaterials for Biomolecule Delivery and Understanding Cell-Niche Interactions $10,000
New Faculty I Karl Deisseroth Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny $2,424,209
Tools and Technologies III Anthony Oro A Chromatin Context Tool for Predicting iPS Lineage Predisposition and Tissue Graftability $1,391,125
SEED Grant Mark Kay Novel vectors for gene transfer into human ES cells $574,737
Disease Team Planning Thomas Rando Stem Cell Therapy for Muscular Dystrophy $0
Disease Team Therapy Planning I Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $90,147
Basic Biology IV Michael Cleary Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells $1,244,455
Basic Biology II Aaron Hsueh Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation $1,309,018
Quest - Discovery Stage Research Projects Hiromitsu Nakauchi Novel Rejuvenated T Cell Immunotherapy for Lung Cancer $1,968,456
Transplantation Immunology Christopher Contag Engineering Embryonic Stem Cell Allografts for Operational Tolerance $1,411,338
Quest - Discovery Stage Research Projects Alan Cheng Modulation of the Wnt pathway to restore inner ear function $1,394,870
Basic Biology V Marius Wernig Mechanisms of human induced neuronal cell reprogramming $1,178,370
SEED Grant Thomas Wandless Reprogramming Differentiated Human Cells to a Pluripotent State $380,005
Conference II Joseph Wu 2017 Stanford Drug Discovery and Stem Cell Technology Conference $2,359
Tools and Technologies II Marius Wernig Cellular tools to study brain diseases affecting synaptic transmission $1,664,382
Therapeutic Translational Research Projects Albert Wong 2nd Generation Vaccine for the Treatment of Glioblastoma $2,929,889
Comprehensive Grant Theo Palmer Immunology of neural stem cell fate and function $2,396,000
Conference II Joseph Wu 2018 Stanford Drug Discovery and Stem Cell Technology Conference $15,000
Disease Team Therapy Development - Research Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $19,068,382
Tissue Collection for Disease Modeling Joseph Wu Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases $1,291,832
New Cell Lines Michael Longaker Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts $1,406,636
Conference Joseph Wu Cardiovascular Regenerative Medicine Symposium $9,000
New Faculty I Joanna Wysocka Trithorax and Polycomb methyltransferase complexes in cell fate determination. $2,373,903
Tools and Technologies III Fan Yang Injectable Macroporous Matrices to Enhance Stem Cell Engraftment and Survival $1,438,200
SEED Grant Julien Sage Functions of RB family proteins in human embryonic stem cells $498,609
Late Stage Preclinical Projects Matthew Porteus Genome Editing of Autologous Hematopoietic Stem Cells to Treat Sickle Cell Disease $4,849,363
Disease Team Therapy Planning I Albert Wong Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Basic Biology IV Alexander Dunn Role of mechanical signaling in stem cell self-renewal and differentiation $1,062,998
Early Translational II Michele Calos Stem Cell Therapy for Duchenne Muscular Dystrophy $2,267,261
Quest - Discovery Stage Research Projects Rosa Bacchetta GENE EDITING FOR FOXP3 IN HUMAN HSC $984,228
Transplantation Immunology Robert Negrin Regulatory T cell induced tolerance to ESC transplantation $1,382,658
Therapeutic Translational Research Projects Theodore Leng NeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration $4,238,532
Basic Biology V Gary Steinberg Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery $1,178,370
SEED Grant Kenneth Weinberg Embryonic stem cell-derived thymic epithelial cells $628,793
Patent Assistance Fund Awards Katharine Ku Funding for Patent Applications for CIRM-funded Inventions out of Stanford University $3,525
Basic Biology III Michael Clarke USP16 controls stem cell number: implications for Down Syndrome $1,263,826
Basic Biology I Susan McConnell Identification and characterization of human ES-derived DA neuronal subtypes $1,404,853
Conference II Joseph Wu Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference $7,500
Comprehensive Grant Christopher Zarins Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells $2,454,490
Tools and Technologies III James Dunn Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $773,327
Disease Team Therapy Development - Research Joseph Wu Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $19,060,330
Early Translational IV Michele Calos Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B $1,876,253
New Cell Lines Theo Palmer Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype $1,409,243
Conference Thomas Rando Keystone Symposia, 'The Life of a Stem Cell: From Birth to Death' $50,000
Tools and Technologies II Michele Calos Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation $1,592,897
Tools and Technologies III Sarah Heilshorn Injectable Hydrogels for the Delivery, Maturation, and Engraftment of Clinically Relevant Numbers of Human Induced Pluripotent Stem Cell-Derived Neural Progenitors to the Central Nervous System $1,347,767
New Faculty II Ching-Pin Chang VEGF signaling in adventitial stem cells in vascular physiology and disease $3,005,695
Therapeutic Translational Research Projects Anthony Oro DEBCT: Genetically Corrected, Induced Pluripotent Cell-Derived Epithelial Sheets for Definitive Treatment of Dystrophic Epidermolysis Bullosa $5,107,353
Disease Team Therapy Planning I Robert Robbins Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $73,030
Basic Biology IV Michelle Monje Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain $1,264,248
Disease Team Research I Alfred Lane iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa $11,039,208
Quest - Discovery Stage Research Projects Roel Nusse Preclinical development of human hepatocyte progenitor cells for cell therapy $1,651,643
Transplantation Immunology Judith Shizuru Purified allogeneic hematopoietic stem cells as a platform for tolerance induction $1,233,275
Major Facilities John Hennessy Stanford SIM1 Building $43,578,000
SEED Grant Joseph Wu In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity $623,634
Inception - Discovery Stage Research Projects Helen Blau Prodrug innovation to target muscle stem cells and enhance muscle regeneration $235,834
Basic Biology III Aaron Hsueh Correlated time-lapse imaging and single cell molecular analysis of human embryo development $1,259,733
Basic Biology IV Howard Chang Long noncoding RNAs for pluripotency and cell fate commitment $1,386,627
Basic Biology I Julien Sage The retinoblastoma (RB) gene family in cellular reprogramming $1,357,085
Inception - Discovery Stage Research Projects Phillip Yang Activation of patient-specific endogenous myocardial repair through the exosomes generated from the hypoxic iPSC-derived cardiomyocytes (iCMs). $234,619
Comprehensive Grant Theo Palmer Human oocyte development for genetic, pharmacological and reprogramming applications $2,298,411
Clinical Trial Stage Projects Crystal Mackall Phase 1 Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Adults with Recurrent or Refractory B Cell Malignancies $11,034,982
Disease Team Therapy Development III Irving Weissman Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors $6,505,568
SEED Grant Krishna Shenoy Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium $572,891
Conference Hank Greely Stem Cell Policy: Understanding the Scientific and Legal Challenges Ahead $5,838
Tools and Technologies II Theo Palmer Development of small molecule screens for autism using patient-derived iPS cells $1,797,606
Tools and Technologies III Irving Weissman Identification and isolation of transplantable human hematopoietic stem cells from pluripotent cell lines; two steps from primitive hematopoiesis to transplantable definitive cells, and non-toxic conditioning of hosts for hematopoeitic stem cell transp... $1,271,952
Comprehensive Grant Irving Weissman Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells $2,471,386
Inception - Discovery Stage Research Projects Guillem Pratx Novel metabolic labeling method for tracking stem cells to irradiated salivary glands using PET $235,613
Training Grant I-1 Michael Longaker Stanford CIRM Training Program $3,035,282
Creativity Awards Paul Utz SIMR Program: Stem Cell & Developmental Biology Research Internships $340,611
Disease Team Research I Gary Steinberg Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke $17,244,851
Quest - Discovery Stage Research Projects Matthew Porteus Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells $1,968,456
Transplantation Immunology Kenneth Weinberg Engineered immune tolerance by Stem Cell-derived thymic regeneration $1,271,729
Disease Team Planning Robert Robbins {REDACTED} Cardiovascular Regenerative Team $25,119
SEED Grant Joanna Wysocka Role of Chromatin Modifiers in Regulating Human Embryonic Stem Cell Pluripotency $629,952
Quest - Discovery Stage Research Projects Mark Mercola Multipotent Cardiovascular Progenitor Regeneration of the Myocardium after MI $1,809,234
Basic Biology III Joanna Wysocka Enhancer-mediated gene regulation during early human embryonic development $1,420,618
Basic Biology IV Gerald Crabtree Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch $1,392,150
Basic Biology I Helen Blau Molecular Mechanisms of Reprogramming towards Pluripotency $1,408,332
Inception - Discovery Stage Research Projects Bertha Chen Autologous iPSC-based therapy for radiation induced bladder injury $235,836
Early Translational I Jill Helms Enhancing healing via Wnt-protein mediated activation of endogenous stem cells $6,464,126
Therapeutic Translational Research Projects Bertha Chen Autologous iPSC-derived smooth muscle cell therapy for treatment of urinary incontinence $5,977,155
Research Leadership Hiromitsu Nakauchi Generation of functional cells and organs from iPSCs $5,427,512
SEED Grant Calvin Kuo Differentiation of Human Embryonic Stem Cells to Intestinal Fates $554,176
Conference Joseph Wu Cardiovascular Tissue Engineering Symposium $25,000
Tools and Technologies II Sarah Heilshorn Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels $600,695
Tools and Technologies III Joseph Wu Macaca mulatta as advanced model for predictive preclinical testing of engineered cardiac autografts and allografts $1,689,744
Comprehensive Grant Stefan Heller Generation of inner ear sensory cells from human ES cells toward a cure for deafness $2,330,371
Inception - Discovery Stage Research Projects Hiromitsu Nakauchi Optimizing self-renewal signaling kinetics to stabilize ex vivo hematopoietic stem cell expansion $210,906
Early Translational III Joseph Wu Heart Repair with Human Tissue Engineered Myocardium $4,396,738
New Faculty Physician Scientist Alan Cheng Enhancing hair cell regeneration in mouse and human inner ear $3,088,525
Disease Team Research I Irving Weissman Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells $18,759,276
Conference Julien Sage 3rd International RB conference $10,000
New Faculty I Anne Brunet Molecular mechanisms involved in adult neural stem cell maintenance $2,348,435
Shared Labs Theo Palmer The Stanford University Center for Human Embryonic Stem Cell Research and Education $2,439,590
SEED Grant Phillip Yang In Vivo Molecular Magnetic Resonance Imaging of Human Embryonic Stem Cells in Murine Model of Myocardial Infarction $629,952
Conference II Samuel Strober Third International Workshop on Clinical Tolerance $29,500
Basic Biology III Sean Wu Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells $1,260,537
Basic Biology IV Roel Nusse Asymmetric stem cell division oriented by a local self-renewing signal $1,039,058
Basic Biology II Steven Artandi Self-renewal and senescence in iPS cells derived from patients with a stem cell disease $931,285
Inception - Discovery Stage Research Projects Philip Beachy Curing bladder cancer by replacing corrupted urothelium with differentiated hES cells $210,906
Shared Labs Vittorio Sebastiano The Stanford University Center for Human Embryonic Stem Cell Research and Education $3,434,600
Quest - Discovery Stage Research Projects Vittorio Sebastiano Regenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome $1,251,720
Basic Biology V Xinnan Wang Misregulated Mitophagy in Parkinsonian Neurodegeneration $1,174,943
SEED Grant John Cooke EC regeneration in cerebrovascular ischemia: role of NO $476,995
Clinical Trial Stage Projects Samuel Strober Induction of Tolerance to Combined Kidney and Hematopoietic Progenitor Cell Transplants from HLA Haplotype Matched Living Donors $6,653,266
Tools and Technologies II Brian Rutt Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters $1,833,348
Total:
$367,393,388.00
Icon for xls export